ArticleJournal of molecular medicine (Berlin, Germany)2026
Pressure-mediated mechanosensitive Piezo2 channel is activated in neurogenic bladder and promote bladder fibrosis in children.
Article in Journal of molecular medicine (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Mechanosensitive Piezo2 channels play a critical role in bladder pressure perception and may contribute to bladder fibrosis in patients with neurogenic bladder (NB), a condition that significantly affects quality of life. This study aimed to investigate the expression of Piezo2 and its role in bladder fibrosis using both human and animal models. Bladder tissue samples were obtained from children with NB undergoing ileocystoplasty, along with normal tissues from control subjects. An NB model was established in juvenile Sprague-Dawley rats through spinal nerve transection. Transcriptome analysis revealed the activation of pathways associated with mechanical stimulation, nuclear factor kappa-B (NF-κB) signaling, and epithelial-mesenchymal transition (EMT) in the context of NB. The results indicated that elevated Piezo2 levels were correlated with increased bladder pressure and fibrosis. Cystometry tests demonstrated significant increases in bladder pressure at week 2, followed by slight decreases, although pressure levels remained elevated compared to controls. Stretching experiments conducted on SV-HUC-1 cells showed that Piezo2 activation exacerbated fibrosis through the Ca²⁺/NF-κB/EMT axis, while the use of Piezo2 siRNA mitigated this effect. These findings suggest that Piezo2 channels, activated by increased pressure, accelerate bladder fibrosis via the Ca²⁺/NF-κB/EMT pathway, indicating that Piezo2 inhibition may serve as a potential therapeutic strategy to prevent fibrosis in NB.
Indexed as
Identifiers
42474506What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.